ANAB peer analysis
AnaptysBio (ANAB) against its competitors: price, today's move, 1-year return and market value side by side.
- ANAB's peers: ACRS (Aclaris Therapeutics), ANNX (Annexon), ARTV (Artiva Biotherapeutics), CNTB (Connect Biopharma), DNTH (Dianthus Therapeutics), IMVT (Immunovant), MLTX (MoonLake Immunotherapeutics), ODTX (Odyssey Therapeutics).
ANAB and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.44 | -1.71% | 39.84% | $545.63M |
| ANNX Annexon | $3.41 | 0.00% | -16.01% | $650.51M |
| ARTV Artiva Biotherapeutics | $3.82 | -0.26% | 12.68% | $188.83M |
| CNTB Connect Biopharma | $0.63 | -5.56% | -80.06% | $40.51M |
| DNTH Dianthus Therapeutics | $84.08 | -0.88% | 106.13% | $4.73B |
| IMVT Immunovant | $31.51 | -3.11% | 36.05% | $6.52B |
| MLTX MoonLake Immunotherapeutics | $11.07 | 0.36% | -18.24% | $942.13M |
| ODTX Odyssey Therapeutics | $16.96 | -7.52% | – | $815.23M |
| QTTB Q32 Bio | $8.18 | -3.54% | 285.85% | $244.78M |
| XNCR Xencor | $33.24 | -2.26% | 110.78% | $2.49B |
| ANAB AnaptysBio | $46.63 | -1.62% | 25.99% | $1.39B |